Patent details
EP3489353
Title:
STABLE CELL LINES FOR RETROVIRAL PRODUCTION
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Unitary Effect
Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
02/08/2023
Unitary Effect Status:
Unitary Effect Registered
Request Unitary Effect Accepted:
23/08/2023
Unitary Effect Date:
26/07/2023
Unitary Effect Registration Date:
23/08/2023
Request Unitary Effect Rejected:
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Unitary Effect Request Withdrawal Date:
Unitary Effect request has been accepted, please see the UPP register at the EPO for up-to-date information
UPP register:
EP3489353
SPC Number:
Creation Date:
Basic Information
Publication number:
EP3489353
WO Application Number:
Type:
European Patent Granted for NL
Status:
Unitary Effect Registered
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP19151187.2
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United Kingdom (GB)
Publications:
Dates
Filing date:
21/11/2016
Grant date:
26/07/2023
EP Publication Date:
29/05/2019
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
26/07/2023
EP B1 Publication Date:
26/07/2023
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
20/11/2036
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
26/07/2023
Name:
GlaxoSmithKline Intellectual Property Development
Limited
Address:
980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom (GB)
Inventor
1
Name:
JOHNSON, Sabine
Address:
Stevenage, Hertfordshire SG1 2NY, United Kingdom (GB)
2
Name:
PALLANT, Celeste
Address:
Stevenage, Hertfordshire SG1 2NY, United Kingdom (GB)
3
Name:
VAMVA, Eirini
Address:
Stevenage, Hertfordshire SG1 2NY, United Kingdom (GB)
4
Name:
VINK, Conrad
Address:
Stevenage, Hertfordshire SG1 2NY, United Kingdom (GB)
Priority
1
Priority Patent Number:
201609303
Priority Date:
26/05/2016
Priority Country:
United Kingdom (GB)
2
Priority Patent Number:
201520761
Priority Date:
24/11/2015
Priority Country:
United Kingdom (GB)
Classification
IPC or IDT classification:
C12N 5/10 ;
C12N 7/02 ;
C12N 7/04 ;
C12N 15/85 ;
Publication
Bulletin
1
Bulletin Heading:
UP1
Journal edition number:
39/23
Publication date:
27/09/2023
Description:
European patents with registered Unitary Effect
2
Bulletin Heading:
EP2
Journal edition number:
30/23
Publication date:
26/07/2023
Description:
European patents granted for the Netherlands
European Patent Bulletin
1
Issue number:
202339
Publication date:
27/09/2023
Description:
Unitary Effect Request Acceptance
2
Issue number:
202336
Publication date:
06/09/2023
Description:
Unitary Effect Request Receipt
3
Issue number:
202335
Publication date:
30/08/2023
Description:
Document reprinted after correction (B8, B9)
4
Issue number:
202330
Publication date:
26/07/2023
Description:
Grant (B1)
Annual Fee
Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date
Document type
Document Description
Number of pages
File Type